Findings seen among people with dystonia or spasticity treated with botulinum toxin type A.
Total of 16,583 cases identified in 2015 using National Amyotrophic Lateral Sclerosis Registry.
The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.
Healthy human appendix contains intraneuronal -synuclein aggregates, truncation products.
Patient with ALS describes assisted death as last element of control, while losing control over his body.
Sensitivity, specificity, accuracy values of 79, 84, and 81% for detecting PD from controls.
DBS has been known to generate other movement-related disorders such as dyskinesias, blepharospasm, and hypokinesia.
Patients with ALS require multidisciplinary care and rehabilitative interventions; maximizing independent function and quality of life are the goals.
An inverse relation was observed between epilepsy and cerebral palsy and 5-minute and 10-minute Apgar scores.
Modulate electrical stimulation of the amygdala may improve declarative memory without provoking any emotional reaction.
The corticosteroid was approved to treat Duchenne muscular dystrophy in patients 5 years and older.